Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer

Fig. 7

Expression analysis of MTOR in MSI and MSS CRC. A The boxplot shows the different MTOR expression levels between MSI-H and MSS CRC patients from GSE75316. B Representative IHC staining shows differences in mTOR expression between MSI and MSS CRC tissues. C The western blots show protein expression levels of mTOR and p-mTOR in CRC cell lines. The MSI cell lines RKO and HCT-116 and the MSS cell lines HT-29 and SW-620 are shown. Full-length blots are presented in Supplementary Figs. 3, 4, 5. CRC, colorectal cancer; MSI, microsatellite instability; MSI-H, MSI-high; MSS; microsatellite stable; mTOR, mammalian target of rapamycin

Back to article page